Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0

Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0

Purpose: To evaluate the accuracy of the AVERT PLUS to monitor contrast volume used during angiographic procedures. This will be a first in man prospective observational study of the accuracy of this system to quantify contrast volume used during clinically indicated angiography in the cardiac catheterization laboratory.

Research Design:

The AVERT PLUS is an FDA 510K cleared device which consists of 1) a contrast delivery modulator designed to reduce unnecessary contract dye delivery to the patient during angiography (coronary or peripheral) and 2) a concomitant contrast monitoring system to precisely measure contrast volume delivered to the patient. This will be a first in man prospective observational study of the accuracy of this system to quantify contrast volume used during clinically indicated angiography in the cardiac catheterization laboratory.

Inclusion Criteria:

• Patients undergoing clinically indicated coronary or peripheral angiography

Exclusion Criteria:

• None